drugset / Trial / NCT01349777
Effectiveness of Clopidogrel Resinate in PCI(PRIDE)
Phase 4
Completed
1056 enrolled
CardioVascular Research Foundation
CardioVascular Research Foundation, Korea · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This study is an open label, multi-center, randomized trial, which is designed to evaluate the efficacy and safety of clopidogrel derivative (Pregrel®) therapy for 12 months in patients undergoing PCI compared to conventional clopidogrel (Plavix®).
Timeline
- Start
- 2010-03-15
- Primary completion
- 2017-03-14
- Completion
- 2017-03-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | 75 mg | — |